US Patent 10526409 Antibodies against human NKG2D and uses thereof
Patent 10526409 was granted and assigned to Novo Nordisk on January, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10526409 Antibodies against human NKG2D and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.